PAN-90806

N/A

Report date: 2026/01/27 14:44:18
NME

Base Information

Drug NamePAN-90806
Drug Alias NameOSI-632CP-632CP-547632PAN-90806
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsAngiogenesis inhibitors
TargetsVascular endothelial growth factor receptor 2
Therapy Area/IndicationsWet age-related macular degenerationMacular DegenerationDiabetic Retinopathy +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[7] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPfizer IncOsi Pharmaceutical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhaoke Ophthalmology LtdZhaoke (Guangzhou) Ophthalmology Pharmaceutical Co Ltd
Inactive CompaniesPfizer IncNational Cancer InstitutePanoptica Inc
Active IndicationsWet age-related macular degeneration
Inactive IndicationsMacular DegenerationDiabetic RetinopathyFallopian Tube Neoplasms +[7] 

Other Information

ATC CodeN/A
Related LinksN/A